Literature DB >> 15654687

Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration.

Mahesh N Samtani1, William J Jusko.   

Abstract

This study seeks a route of drug administration that would produce a pharmacokinetic profile for dexamethasone not significantly different from the intravenous route in female rats and would offer reproducible drug input with minimal stress to the animals. The intramuscular (i.m.) route of drug administration vs intravenous (i.v.) injection were compared in three female Wistar rats administered 1 mg/kg dexamethasone phosphate. Dexamethasone plasma concentrations were measured by a normal phase HPLC assay for 12 h after drug administration. Dexamethasone exhibited monoexponential behavior after intravenous dosing and was absorbed rapidly after intramuscular dosing (absorption half-life of 14 min) with 86% bioavailability. Dexamethasone had a terminal half-life of 2.3 h after drug administration by either route. The volume of distribution of 0.78 l/kg and the clearance of 0.23 l/h/kg are in good agreement with reported pharmacokinetic parameters in male rats. Intravenous dosing can be replaced by intramuscular dosing without causing any marked difference in dexamethasone pharmacokinetics. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654687      PMCID: PMC4178533          DOI: 10.1002/bdd.435

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  12 in total

1.  Glucocorticoid involvement in suppression of NK activity following surgery in rats.

Authors:  Guy Shakhar; Barak Blumenfeld
Journal:  J Neuroimmunol       Date:  2003-05       Impact factor: 3.478

2.  The route of absorption of intraperitoneally administered compounds.

Authors:  G Lukas; S D Brindle; P Greengard
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

3.  A chronic arterial and venous cannulation method for freely moving rats.

Authors:  P Lestage; P A Vitte; J P Rolinat; R Minot; E Broussolle; P Bobillier
Journal:  J Neurosci Methods       Date:  1985-05       Impact factor: 2.390

4.  Integrated QSPR--pharmacodynamic model of genomic effects of several corticosteroids.

Authors:  Donald E Mager; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharm Sci       Date:  2003-04       Impact factor: 3.534

5.  Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats.

Authors:  Mahesh N Samtani; Matthias Schwab; Peter W Nathanielsz; William J Jusko
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

6.  Influence of protein-calorie malnutrition on the pharmacokinetics, placental transfer and tissue localization of dexamethasone in rats.

Authors:  D R Varma; T L Yue
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

7.  Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: nonlinear and sequential first-pass elimination.

Authors:  A N Kong; W J Jusko
Journal:  J Pharm Sci       Date:  1991-05       Impact factor: 3.534

8.  Receptor/gene-mediated pharmacodynamic effects of methylprednisolone on phosphoenolpyruvate carboxykinase regulation in rat liver.

Authors:  Jin Y Jin; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2004-01-13       Impact factor: 4.030

9.  Stabilization and HPLC analysis of betamethasone sodium phosphate in plasma.

Authors:  Mahesh N Samtani; Matthias Schwab; Peter W Nathanielsz; William J Jusko
Journal:  J Pharm Sci       Date:  2004-03       Impact factor: 3.534

10.  Anti-inflammatory and ulcerogenic effects and pharmacokinetics of dexamethasone in protein-deficient rats.

Authors:  D R Varma; S Mulay
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

View more
  22 in total

1.  Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats.

Authors:  Anasuya Hazra; Nancy A Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

2.  Stability of dexamethasone sodium phosphate in rat plasma.

Authors:  Mahesh N Samtani; William J Jusko
Journal:  Int J Pharm       Date:  2005-09-14       Impact factor: 5.875

3.  Physiologically Based Pharmacokinetics of Dexamethasone in Rats.

Authors:  Dawei Song; Le Sun; Debra C DuBois; Richard R Almon; Shengnan Meng; William J Jusko
Journal:  Drug Metab Dispos       Date:  2020-06-29       Impact factor: 3.922

4.  Modeling Sex Differences in Anti-inflammatory Effects of Dexamethasone in Arthritic Rats.

Authors:  Dawei Song; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2018-09-06       Impact factor: 4.200

5.  A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats.

Authors:  Liang Li; Zai-quan Li; Chen-hui Deng; Miao-ran Ning; Han-qing Li; Shan-shan Bi; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

6.  Precocious glucocorticoid exposure reduces skeletal muscle satellite cells in the fetal rat.

Authors:  Ganga Gokulakrishnan; Xiaoyan Chang; Ryan Fleischmann; Marta L Fiorotto
Journal:  J Endocrinol       Date:  2017-01-17       Impact factor: 4.286

7.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.

Authors:  Vivaswath S Ayyar; Dawei Song; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

8.  Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.

Authors:  Anasuya Hazra; Nancy Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-06-26       Impact factor: 2.745

9.  Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis.

Authors:  Justin C Earp; Nancy A Pyszczynski; Diana S Molano; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2008-09       Impact factor: 1.627

10.  Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats.

Authors:  Anasuya Hazra; Nancy Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2007-09       Impact factor: 1.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.